AI:AM — AI Genetics and Rare-Disease Diagnosis · September 30, 2026

Podcast: AI:AM · Prakash Narayanan & Nathan Labenz

Opublikowano: 2026-10-05

Joel Borgen, author of The Receipt Horizon, discusses writing with ChatGPT and Claude, editorial judgment, and how personalized AI art could change shared culture. Daniel McKinnon, CEO of Gamow Labs, explains how the company acquired a former drug-development lab to test uncertain genetic variants and improve rare-disease diagnosis, alongside discussion of AI agents, OpenAI’s enterprise push, and the need for human oversight. Chapters (0:00) AI novels and rare-disease genetics (1:26) Can Astra Ultrafast keep developers in flow? (2:09) ChatGPT sign-in makes OpenAI harder to bypass (2:37) OpenAI apps will run rival models to...